Pennsylvania 2023-2024 Regular Session

Pennsylvania House Bill HB2120

Introduced
3/14/24  

Caption

Further providing for definitions and for misbranding.

Impact

The passage of HB2120 would have a significant effect on state laws concerning product labeling and advertising regulations. Clearer definitions would likely lead to more stringent enforcement of misbranding laws, thereby reinforcing protections for consumers. This could result in an increase in compliance costs for businesses, especially those involved in manufacturing and distributing goods, as they may need to update their labeling practices to adhere to the new definitions provided in the bill.

Summary

House Bill 2120 focuses on further refining definitions related to misbranding in regulatory practices. This bill aims to clarify ambiguities present in existing legislation to improve regulatory compliance and consumer understanding. By providing clearer definitions, HB2120 seeks to enhance the accountability of manufacturers and suppliers, ensuring that the public is accurately informed about the products they purchase.

Sentiment

The sentiment surrounding HB2120 appears to be cautiously optimistic among consumer protection advocates, who believe that the bill represents a step forward in ensuring ethical marketing and labeling practices. However, there are concerns from industry stakeholders about the potential impact on business operations and the costs associated with changing labeling practices to meet the new requirements. The discussion reflects a balance between consumer rights and business interests, highlighting the ongoing debate over regulatory measures in consumer goods.

Contention

Notable points of contention in discussions around HB2120 include concerns from businesses about the practical implications of more rigorous definitions of misbranding. Some members of the legislature voiced apprehension that the bill might impose excessive burdens on businesses that are already navigating complex regulatory environments. Opponents of the bill argue that while clarity is essential, the changes could lead to unintended consequences that may ultimately harm consumers by reducing market choices.

Companion Bills

No companion bills found.

Previously Filed As

PA SB1166

Further providing for definitions and for misbranding.

PA SB628

Further providing for definitions and for misbranding.

PA SB509

Further providing for definitions.

PA HB1245

Further providing for definitions and for prohibited acts and penalties.

PA SB405

Further providing for definitions.

PA HB809

Further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.

PA SB1169

Further providing for definitions and for drug overdose medication.

PA HB1661

Further providing for schedules of controlled substances; and providing for secure storage of xylazine.

PA SB81

Further providing for definitions and for unlawful acts.

PA HB977

Further providing for prohibited acts and penalties.

Similar Bills

No similar bills found.